Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia

被引:0
作者
Shyamal H. Mehta
Rajesh Pahwa
Caroline M. Tanner
Robert A. Hauser
Reed Johnson
机构
[1] Mayo Clinic—Scottsdale,Department of Neurology
[2] University of Kansas Medical Center,Department of Neurology
[3] University of California,Department of Neurology
[4] University of South Florida,USF Parkinson’s Disease and Movement Disorders Center Parkinson Foundation Center of Excellence
[5] Tampa,undefined
[6] Adamas Pharmaceuticals,undefined
[7] Inc.,undefined
来源
Neurology and Therapy | 2021年 / 10卷
关键词
Amantadine; Depression; Depressive disorder; Dyskinesias; Hallucinations; Parkinson’s disease; Sleep;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:307 / 320
页数:13
相关论文
共 113 条
  • [1] Barone P(2009)The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease Mov Disord 24 1641-1649
  • [2] Antonini A(2011)Parkinson's disease: the non-motor issues Parkinsonism Relat Disord 17 717-723
  • [3] Colosimo C(2013)Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life J Am Geriatr Soc 61 1714-1721
  • [4] Marconi R(2006)International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study Mov Disord 21 916-923
  • [5] Morgante L(2002)Non-recognition of depression and other non-motor symptoms in Parkinson's disease Parkinsonism Relat Disord 8 193-197
  • [6] Avarello TP(2010)What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord 25 2493-2500
  • [7] Chaudhuri KR(2010)The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire Mov Disord 25 704-709
  • [8] Odin P(2010)Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards subcommittee of the american academy of neurology Neurology 74 924-931
  • [9] Antonini A(2000)What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69 308-312
  • [10] Martinez-Martin P(2008)Movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results Mov Disord 23 2129-2170